RILUZOL AUROVITAS 50 mg FILM-COATED TABLETS
How to use RILUZOL AUROVITAS 50 mg FILM-COATED TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Riluzol Aurovitas 50 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, because it contains important information for you.
- Keep this package leaflet, as you may need to read it again.
- If you have any questions, consult your doctor or pharmacist.
- This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
- If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this package leaflet. See section 4.
Contents of the Package Leaflet:
- What is Riluzol Aurovitas and what is it used for
- What you need to know before taking Riluzol Aurovitas
- How to take Riluzol Aurovitas
- Possible side effects
- Storage of Riluzol Aurovitas
- Package Contents and Additional Information
1. What is Riluzol Aurovitas and what is it used for
What is Riluzol Aurovitas
The active ingredient of Riluzol Aurovitas is riluzole, which acts on the nervous system.
What is Riluzol Aurovitas used for
Riluzole is used in patients with amyotrophic lateral sclerosis (ALS).
ALS is a type of motor neuron disease that affects the nerve cells responsible for sending signals to the muscles, causing weakness, muscle loss, and paralysis.
The destruction of nerve cells in motor neuron disease can be caused by an excess of glutamate (a chemical messenger) in the brain and spinal cord. Riluzole stops the release of glutamate, which may help prevent damage to nerve cells.
For more information, consult your doctor about ALS and the reason why you have been prescribed this medication.
2. What you need to know before taking Riluzol Aurovitas
Do not take Riluzol Aurovitas
- if you are allergic to riluzole or any of the other components of this medication (listed in section 6).
- if you have any liver disease or high blood levels of certain liver enzymes (transaminases).
- if you are pregnant or breastfeeding.
Warnings and Precautions
Consult your doctor before starting to use Riluzol Aurovitas:
- if you have liver problems: yellowing of the skin or whites of the eyes (jaundice), generalized itching, feeling of dizziness, nausea.
- if your kidneys do not function properly.
- if you have a fever: it may be due to a lower number of white blood cells, which can increase the risk of infection.
If you are affected by any of the above circumstances or if you are unsure, inform your doctor so that they can tell you what to do.
Children and Adolescents
If you are under 18 years of age. Riluzole is not recommended for use in children, as there is no available information in this population.
Other Medications and Riluzol Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
DO NOT take riluzole if you are pregnant or suspect you may be pregnant, or if you are breastfeeding.
Driving and Using Machines
You can drive or operate tools or machines, unless you feel dizzy or confused after taking this medication.
Riluzol Aurovitas contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
3. How to take Riluzol Aurovitas
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is one tablet twice a day.
The tablets should be taken orally, every 12 hours, at the same time each day (e.g., morning and evening).
If you take more Riluzol Aurovitas than you should
If you have taken too many tablets, contact your doctor or go to the emergency department of the nearest hospital.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount administered.
If you forget to take Riluzol Aurovitas
Do not take a double dose to make up for the missed dose.
If you forget to take a tablet, skip this dose and take the next tablet at the usual time.
If you interrupt treatment with Riluzol Aurovitas
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
4. Possible Side Effects
Like all medications, this medication can cause side effects, although not everyone will experience them.
Important
You must stop taking riluzole and see your doctor immediately if you experience symptoms of angioedema, such as:
- swelling of the face, tongue, or pharynx.
- difficulty swallowing.
- hives and difficulty breathing.
Consult your doctor immediately
- if you have a fever (increased temperature), because riluzole can cause a decrease in the number of white blood cells. Your doctor may tell you to have blood tests to monitor the number of white blood cells, which are important in fighting infections.
- if you experience any of the following symptoms: yellowing of the skin or whites of the eyes (jaundice), generalized itching, feeling of dizziness, or nausea, as they may be signs of liver disease (hepatitis). Your doctor may perform periodic blood tests while you are taking riluzole to ensure this does not occur.
- if you experience coughing or difficulty breathing, as this could be a sign of lung disease (called interstitial lung disease).
Very Common Side Effects (may affect more than 1 in 10 people)
- fatigue.
- discomfort.
- increased levels of certain liver enzymes (transaminases) in the blood. This may be associated with jaundice* (see section 2).
Common Side Effects (may affect up to 1 in 10 people)
- dizziness.
- drowsiness.
- headache.
- numbness or tingling sensation in the mouth.
- increased heart rate.
- abdominal pain.
- vomiting.
- diarrhea.
- pain.
Uncommon Side Effects (may affect up to 1 in 100 people)
- allergic reactions, swelling of the face, lips, tongue, or throat associated with difficulty breathing and/or swallowing (angioedema).
- anemia.
- pancreatitis (inflammation of the pancreas).
Frequency Not Known (cannot be estimated from available data)
- skin rash.
- study data indicate that Asian patients may be more susceptible to alterations in liver function tests than Caucasian patients.
Reporting Side Effects:
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
5. Storage of Riluzol Aurovitas
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and blister. The expiration date is the last day of the month indicated.
Blister packs (aluminum/aluminum). This medication does not require special storage conditions.
Blister packs (aluminum/PVC): Keep the blister pack in the outer packaging to protect it from light. This medication does not require special temperature storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
6. Package Contents and Additional Information
Composition of Riluzol Aurovitas
- The active ingredient is riluzole. Each film-coated tablet contains 50 mg of riluzole.
- The other ingredients are:
Tablet core:calcium hydrogen phosphate, pregelatinized corn starch without gluten, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate.
Tablet coating:OPADRY AMB white 03F28689, which contains: hypromellose, macrogol 6000, titanium dioxide (E171).
Appearance of the Product and Package Contents
Film-coated tablets, oval and biconvex, white or almost white, and marked with RL 50.
Blister packs containing 28, 30, 56, and 60 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Phone: 91 630 86 45
Fax: 91 630 26 64
Manufacturer
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700 - 487 Amadora
Portugal
This medication is authorized in the Member States of the European Economic Area under the following names:
Belgium: Riluzol AB 50 mg film-coated tablets
Spain: Riluzol Aurovitas 50 mg film-coated tablets EFG
France: Riluzole Arrow 50 mg, film-coated tablet
Italy: Riluzolo Aurobindo 50 mg film-coated tablets
Portugal: Riluzol Aurovitas
Date of the Last Revision of this Package Leaflet: February 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to RILUZOL AUROVITAS 50 mg FILM-COATED TABLETSDosage form: ORALLY DISINTEGRATING TABLET/LIOTAB, 50 mgActive substance: riluzoleManufacturer: Zambon S.P.A.Prescription requiredDosage form: TABLET, 50 mgActive substance: riluzoleManufacturer: Sanofi Winthrop IndustriePrescription requiredDosage form: TABLET, 50 mgActive substance: riluzoleManufacturer: Pro.Med.Cs Praha A.S.Prescription required
Online doctors for RILUZOL AUROVITAS 50 mg FILM-COATED TABLETS
Discuss questions about RILUZOL AUROVITAS 50 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions